We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > PHASE

News List

Hong Kong, S.A.R., China government endorses INDICAID(R) in visitation resumption arrangements prnasia
May 10, 2021
COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong, S.A.R., China biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitati
PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit prnasia
July 20, 2020
PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit.
Influenza A vaccine enters Phase IIb trial europeanpharmaceuticalreview
June 10, 2019
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.